Imaging Patterns in ADPKD and the Problem With Kidney Stones Patients with autosomal dominant polycystic kidney disease have more kidney stones than the general population, with a consequent ...

At that dose the drug showed improvements in imaging-based biomarkers for ADPKD, including a reduction in total kidney volume, that the company said suggests it can “address the underlying ...

But maybe Edgar to start with you and with your expertise in the condition of autosomal dominant polycystic kidney disease, ...

A multicenter study from the Consortium for Radiologic Imaging Studies of Polycystic ... renal function in patients with autosomal dominant polycystic kidney disease (ADPKD).

A study of real-world patients with ADPKD supports tolvaptan’s role in slowing annual eGFR decline. Treatment with tolvaptan modestly but significantly attenuates long-term decline of kidney ...

Regulus’ lead asset, farabursen, is a potential first-in-class, next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD). The agreed ...